14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

$323.92 (0.84%)

Volume: 597.961k

Closed: May 23, 2022

Hollow Logo Score: -3.940

DexCom Stock Forecast

BUY SELL NASDAQ:DXCM
$323.92 (0.84%)

Volume: 597.961k

Closed: May 23, 2022

Score Hollow Logo -3.940

DexCom Stock Forecast NASDAQ:DXCM

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-17 62.08% Citigroup $630.00 $525.00 Maintains Buy
2022-04-29 51.89% Morgan Stanley $514.00 $492.00 Maintains Equal-Weight
2022-04-29 50.04% Raymond James $538.00 $486.00 Maintains Outperform
2022-04-29 54.36% SVB Leerink $565.00 $500.00 Maintains Outperform
2022-04-29 48.18% Piper Sandler $725.00 $480.00 Maintains Overweight
2022-02-11 58.68% Morgan Stanley $570.00 $514.00 Maintains Equal-Weight
2022-02-03 65.16% BTIG $535.00 Upgrades Neutral Buy
2022-01-19 77.51% Wells Fargo $575.00 Upgrades Equal-Weight Overweight
2022-01-19 66.09% Raymond James $618.00 $538.00 Maintains Outperform
2022-01-07 75.97% Morgan Stanley $576.00 $570.00 Maintains Equal-Weight
2022-01-07 79.06% Guggenheim $580.00 Upgrades Neutral Buy
2021-11-03 131.54% Piper Sandler $675.00 $750.00 Maintains Overweight
2021-11-01 90.79% Raymond James $515.00 $618.00 Maintains Outperform
2021-10-29 77.82% Morgan Stanley $510.00 $576.00 Maintains Equal-Weight
2021-10-29 120.73% SVB Leerink $500.00 $715.00 Maintains Outperform
2021-10-18 - Guggenheim - Downgrades Buy Neutral
2021-09-16 100.67% Piper Sandler $550.00 $650.00 Maintains Overweight
2021-08-02 57.45% Morgan Stanley $410.00 $510.00 Maintains Equal-Weight
2021-07-30 62.08% Oppenheimer $500.00 $525.00 Maintains Outperform
2021-07-30 69.8% Piper Sandler $500.00 $550.00 Maintains Overweight
2021-07-30 54.36% Canaccord Genuity $455.00 $500.00 Maintains Buy
2021-07-30 58.99% Raymond James $466.00 $515.00 Maintains Outperform
2021-07-30 46.64% Wells Fargo $380.00 $475.00 Maintains Equal-Weight
2021-07-30 54.36% SVB Leerink $485.00 $500.00 Maintains Outperform
2021-05-28 17.31% Wells Fargo $380.00 Upgrades Underweight Equal-Weight
2021-05-25 54.36% Barclays $500.00 Initiates Coverage On Overweight
2021-04-30 40.47% Canaccord Genuity $445.00 $455.00 Maintains Buy
2021-04-30 43.86% Raymond James $449.00 $466.00 Maintains Outperform
2021-04-30 50.65% Citigroup $480.00 $488.00 Maintains Buy
2021-04-15 35.22% Atlantic Equities $438.00 Initiates Coverage On Overweight
2021-02-12 38.61% Raymond James $415.00 $449.00 Maintains Outperform
2021-02-12 48.18% Citigroup $485.00 $480.00 Maintains Buy
2021-02-12 26.57% Morgan Stanley $402.00 $410.00 Maintains Equal-Weight
2020-12-15 24.1% Morgan Stanley $398.00 $402.00 Maintains Equal-Weight
2020-12-10 34.29% Canaccord Genuity $475.00 $435.00 Maintains Buy
2020-10-28 46.64% Canaccord Genuity $500.00 $475.00 Maintains Buy
2020-10-28 46.64% Stifel $500.00 $475.00 Maintains Buy
2020-10-28 35.22% Raymond James $450.00 $438.00 Maintains Outperform
2020-10-28 22.87% Morgan Stanley $428.00 $398.00 Maintains Equal-Weight
2020-10-02 8.05% Wells Fargo $420.00 $350.00 Downgrades Equal-Weight Underweight
2020-07-29 43.55% Piper Sandler $450.00 $465.00 Maintains Overweight
2020-07-29 23.49% UBS $335.00 $400.00 Maintains Neutral
2020-07-29 54.36% Stifel $385.00 $500.00 Maintains Buy
2020-07-29 38.92% Raymond James $395.00 $450.00 Maintains Outperform
2020-07-29 32.13% Morgan Stanley $377.00 $428.00 Maintains Equal-Weight
2020-07-29 49.73% SVB Leerink $465.00 $485.00 Maintains Outperform
2020-06-17 54.36% B of A Securities $375.00 $500.00 Maintains Buy
2020-06-09 21.94% Raymond James $360.00 $395.00 Maintains Outperform
2020-05-27 38.92% Piper Sandler $375.00 $450.00 Maintains Overweight
2020-05-14 29.66% Wells Fargo $420.00 Initiates Coverage On Equal-Weight
2020-04-30 3.42% UBS $275.00 $335.00 Maintains Neutral
2020-04-29 18.86% Stifel $270.00 $385.00 Maintains Buy
2020-04-29 21.94% Guggenheim $385.00 $395.00 Maintains Buy
2020-04-29 11.45% Citigroup $330.00 $361.00 Maintains Buy
2020-04-29 15.77% Piper Sandler $300.00 $375.00 Maintains Overweight
2020-04-29 11.14% JP Morgan $300.00 $360.00 Maintains Overweight
2020-04-29 16.39% Morgan Stanley $278.00 $377.00 Maintains Equal-Weight
2020-04-29 11.14% Oppenheimer $305.00 $360.00 Maintains Outperform
2020-04-29 11.14% Raymond James $350.00 $360.00 Maintains Outperform
2020-04-27 8.05% Raymond James $288.00 $350.00 Maintains Outperform
2020-03-27 -14.18% Morgan Stanley $270.00 $278.00 Maintains Equal-Weight
2020-03-23 -25.91% Stephens & Co. $300.00 $240.00 Maintains Overweight
2020-03-06 -5.84% Oppenheimer $285.00 $305.00 Maintains Outperform
2020-03-05 1.88% Citigroup $330.00 Initiates Coverage On Buy
2020-02-18 -16.65% Morgan Stanley $225.00 $270.00 Maintains Equal-Weight
2020-02-14 -12.02% Oppenheimer $250.00 $285.00 Maintains Outperform
2020-02-14 -20.35% CFRA $205.00 $258.00 Maintains Hold
2020-02-14 -7.38% Canaccord Genuity $255.00 $300.00 Maintains Buy
2020-02-14 -11.09% Raymond James $258.00 $288.00 Maintains Outperform
2020-02-14 -15.1% UBS $250.00 $275.00 Maintains Neutral
2020-02-14 -7.38% Stephens & Co. $255.00 $300.00 Maintains Overweight
2019-12-20 -21.28% JP Morgan $215.00 $255.00 Maintains Overweight
2019-12-18 -22.82% B of A Securities $220.00 $250.00 Reiterates Buy
2019-12-17 -30.54% Morgan Stanley $202.00 $225.00 Maintains Equal-Weight
2019-11-07 -25.91% Baird $195.00 $240.00 Maintains Outperform
2019-11-07 -33.63% JP Morgan $190.00 $215.00 Maintains Overweight
2019-11-07 -42.89% UBS $160.00 $185.00 Maintains Neutral
2019-11-07 -37.64% Morgan Stanley $175.00 $202.00 Maintains Equal-Weight
2019-11-07 -38.26% Stifel $190.00 $200.00 Maintains Buy
2019-11-07 -39.8% Canaccord Genuity $185.00 $195.00 Maintains Buy
2019-11-07 -38.26% Piper Sandler $182.00 $200.00 Maintains Overweight
2019-11-07 -41.65% Raymond James $172.00 $189.00 Maintains Outperform
2019-10-23 -41.34% Stifel $190.00 Initiates Coverage On Buy
2019-09-03 -41.34% BMO Capital $180.00 $190.00 Maintains Outperform
2019-08-29 -39.8% Baird $186.00 $195.00 Maintains Outperform
2019-08-01 -42.89% B of A Securities $162.00 $185.00 Maintains Buy
2019-08-01 -42.58% Baird $180.00 $186.00 Maintains Outperform
2019-08-01 -41.34% JP Morgan $170.00 $190.00 Maintains Overweight
2019-08-01 -50.61% UBS $140.00 $160.00 Maintains Neutral
2019-08-01 -46.9% Raymond James $150.00 $172.00 Maintains Outperform

DXCM Stock Trend

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $303.52 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -17.61% during the next 3 months and, with a 90% probability hold a price between $250.07 and $389.69 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-25 $301.86 $386.59 $471.32
2022-05-26 $300.21 $384.93 $469.66
2022-05-27 $298.55 $383.28 $468.01
2022-05-31 $296.89 $381.62 $466.35
2022-06-01 $295.23 $379.96 $464.69
2022-06-02 $293.58 $378.31 $463.03
2022-06-03 $291.92 $376.65 $461.38
2022-06-06 $290.26 $374.99 $459.72
2022-06-07 $288.61 $373.34 $458.06
2022-06-08 $286.95 $371.68 $456.41
2022-06-09 $285.29 $370.02 $454.75
2022-06-10 $283.64 $368.36 $453.09
2022-06-13 $281.98 $366.71 $451.44
2022-06-14 $280.32 $365.05 $449.78
2022-06-15 $278.66 $363.39 $448.12
2022-06-16 $277.01 $361.74 $446.46
2022-06-17 $275.35 $360.08 $444.81
2022-06-21 $273.69 $358.42 $443.15
2022-06-22 $272.04 $356.77 $441.49
2022-06-23 $270.38 $355.11 $439.84
2022-06-24 $268.72 $353.45 $438.18
2022-06-27 $267.07 $351.79 $436.52
2022-06-28 $265.41 $350.14 $434.87
2022-06-29 $263.75 $348.48 $433.21
2022-06-30 $262.10 $346.82 $431.55
2022-07-01 $260.44 $345.17 $429.90
2022-07-05 $258.78 $343.51 $428.24
2022-07-06 $257.12 $341.85 $426.58
2022-07-07 $255.47 $340.20 $424.92
2022-07-08 $253.81 $338.54 $423.27

About DexCom

DexCom DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes DexCom G4 PLATINUM system for continuous use by ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT